Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders
- ANAVEX® Life Sciences Corp.
- Jun 11, 2016
- 1 min read
Gordon Research Conference for Fragile X and Autism-Related Disorders, Mount Snow, VT
Patricia Cogram, Daniel Klamer, Nell Rebowe, Jeffrey Sprouse, Christopher U. Missling
